Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant

Journal Title: The AAPS Journal - Year 2010, Vol 12, Issue 2

Abstract

Nasal administration of influenza vaccine has the potential to facilitate influenza control and prevention. However, when administered intranasally (i.n.), commercially available inactivated vaccines only generate systemic and mucosal immune responses if strong adjuvants are used, which are often associated with safety problems. We describe the successful use of a safe adjuvant Gram-positive enhancer matrix (GEM) particles derived from the food-grade bacterium Lactococcus lactis for i.n. vaccination with subunit influenza vaccine in mice. It is shown that simple admixing of the vaccine with the GEM particles results in a strongly enhanced immune response. Already after one booster, the i.n. delivered GEM subunit vaccine resulted in hemagglutination inhibition titers in serum at a level equal to the conventional intramuscular (i.m.) route. Moreover, i.n. immunization with GEM subunit vaccine elicited superior mucosal and Th1 skewed immune responses compared to those induced by i.m. and i.n. administered subunit vaccine alone. In conclusion, GEM particles act as a potent adjuvant for i.n. influenza immunization.

Authors and Affiliations

Vinay Saluja, Jean P. Amorij, Maarten L. van Roosmalen, Kees Leenhouts, Anke Huckriede, Wouter L. J. Hinrichs, Henderik W. Frijlink

Keywords

Related Articles

Epigenetic Cancer Prevention Mechanisms in Skin Cancer

Epigenetics is an important emerging area for study of mechanisms of cancer prevention. In recent years, it has been realized that cancer prevention agents, derived from natural dietary sources, impact cancer cell surviv...

Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition

The biotechnology segment of the overall biopharma industry has existed for only about 40–45 years, as a driver of new product development. This driving force was initiated with the FDA approval of recomb...

Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales

The online version of this article (doi:10.1208/s12248-010-9230-0) contains supplementary material, which is available to authorized users.

Renal Organic Anion Transporters (SLC22 Family): Expression, Regulation, Roles in Toxicity, and Impact on Injury and Disease

Organic solute flux across the basolateral and apical membranes of renal proximal tubule cells is a key process for maintaining systemic homeostasis. It represents an important route for the elimination of metabolic wast...

Nanoparticles Containing Anti-inflammatory Agents as Chemotherapy Adjuvants: Optimization and In Vitro Characterization

The pre-administration of dexamethasone (DEX) has previously been shown to enhance the anti-tumor efficacy of chemotherapeutic agents. The delivery of anti-inflammatory agents specifically to tumors via nanoparticle carr...

Download PDF file
  • EP ID EP681365
  • DOI  10.1208/s12248-009-9168-2
  • Views 69
  • Downloads 0

How To Cite

Vinay Saluja, Jean P. Amorij, Maarten L. van Roosmalen, Kees Leenhouts, Anke Huckriede, Wouter L. J. Hinrichs, Henderik W. Frijlink (2010). Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant. The AAPS Journal, 12(2), -. https://europub.co.uk./articles/-A-681365